2018
The Association of Extent of Axillary Surgery and Survival in Women with N2–3 Invasive Breast Cancer
Park TS, Thomas SM, Rosenberger LH, Fayanju OM, Plichta JK, Blitzblau RC, Ong CT, Hyslop T, Hwang ES, Greenup RA. The Association of Extent of Axillary Surgery and Survival in Women with N2–3 Invasive Breast Cancer. Annals Of Surgical Oncology 2018, 25: 3019-3029. PMID: 29978365, PMCID: PMC6474911, DOI: 10.1245/s10434-018-6587-2.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAxillaBiomarkers, TumorBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, LobularFemaleFollow-Up StudiesHumansLymph Node ExcisionMastectomyMiddle AgedNeoplasm InvasivenessPrognosisReceptor, ErbB-2Receptors, EstrogenReceptors, ProgesteroneSentinel Lymph Node BiopsySurvival RateYoung AdultConceptsInvasive breast cancerNational Cancer Data BaseAdvanced nodal diseaseAxillary surgeryOverall survivalBreast cancerNeoadjuvant chemotherapyNodal diseaseImproved survivalAxillary lymph node dissectionGrade 3 diseaseReceipt of SLNBLymph node dissectionInvasive ductal cancerBreast cancer patientsStandard of careAssociation of extentAdjuvant chemotherapyAxillary lymphadenectomyChemotherapy useCN3 diseaseNeoadjuvant settingEndocrine therapyN3 patientsNode dissection
2017
Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011
Ong CT, Thomas SM, Blitzblau RC, Fayanju OM, Park TS, Plichta JK, Rosenberger LH, Hyslop T, Shelley Hwang E, Greenup RA. Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011. Annals Of Surgical Oncology 2017, 24: 3559-3566. PMID: 28879416, PMCID: PMC5994237, DOI: 10.1245/s10434-017-6075-0.Peer-Reviewed Original ResearchConceptsAxillary lymph node dissectionBreast cancer patientsAxillary surgeryPatient ageTumor subtypesCancer patientsAmerican CollegeSurgeons Oncology Group Z0011 trialEarly-stage breast cancer patientsNational Cancer Data BaseHuman epidermal growth factor 2Epidermal growth factor 2CN0 breast cancerLimited nodal diseaseUse of SLNBLymph node dissectionTriple-negative diseaseBackgroundThe American CollegeYears of ageACOSOG Z0011ConclusionsAmong womenPatients 70Z0011 trialNodal diseaseNode dissection